Moderate hypothermia in neonatal encephalopathy: Safety outcomes

Dorothea J. Eicher, Carol L. Wagner, Lakshmi P. Katikaneni, Thomas C. Hulsey, W. Thomas Bass, David A. Kaufman, Michael J. Horgan, Sheila Languani, Jatinder J Bhatia, Lawrence M. Givelichian, Koravangatta Sankaran, Jerome Y. Yager

Research output: Contribution to journalArticle

199 Citations (Scopus)

Abstract

Hypoxic-ischemic injury may cause multisystem organ damage with significant aberrations in clotting, renal, and cardiac functions. Systemic hypothermia may aggravate these medical conditions, such as bradycardia and increased clotting times, and very little safety data in neonatal hypoxic-ischemic injury is available. This study reports a multicenter, randomized, controlled pilot trial of moderate systemic hypothermia (33°C) vs normothermia (37°C) for 48 hours in infants with neonatal encephalopathy instituted within 6 hours of birth or hypoxic-ischemic event. The best outcome measures of safety were determined, comparing rates of adverse events between normothermia and hypothermia groups. A total of 32 hypothermia and 33 normothermia neonates were enrolled in seven centers. Adverse events and serious adverse effects were collected by the study team during the hospital admission, monitored by an independent study monitor, and reported to Institutional Review Boards and the Data and Safety Monitoring Committee. The following adverse events were observed significantly more commonly in the hypothermia group: more frequent bradycardia and lower heart rates during the period of hypothermia, longer dependence on pressors, higher prothrombin times, and lower platelet counts with more patients requiring plasma and platelet transfusions. Seizures as an adverse event were more common in the hypothermia group. These observed side effects of 48 hours of moderate systemic hypothermia were of mild to moderate severity and manageable with minor interventions.

Original languageEnglish (US)
Pages (from-to)18-24
Number of pages7
JournalPediatric Neurology
Volume32
Issue number1
DOIs
StatePublished - Jan 1 2005

Fingerprint

Brain Diseases
Hypothermia
Safety
Bradycardia
Clinical Trials Data Monitoring Committees
Platelet Transfusion
Research Ethics Committees
Prothrombin Time
Wounds and Injuries
Platelet Count
Seizures
Randomized Controlled Trials
Heart Rate
Outcome Assessment (Health Care)
Parturition
Newborn Infant
Kidney

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Eicher, D. J., Wagner, C. L., Katikaneni, L. P., Hulsey, T. C., Bass, W. T., Kaufman, D. A., ... Yager, J. Y. (2005). Moderate hypothermia in neonatal encephalopathy: Safety outcomes. Pediatric Neurology, 32(1), 18-24. https://doi.org/10.1016/j.pediatrneurol.2004.06.015

Moderate hypothermia in neonatal encephalopathy : Safety outcomes. / Eicher, Dorothea J.; Wagner, Carol L.; Katikaneni, Lakshmi P.; Hulsey, Thomas C.; Bass, W. Thomas; Kaufman, David A.; Horgan, Michael J.; Languani, Sheila; Bhatia, Jatinder J; Givelichian, Lawrence M.; Sankaran, Koravangatta; Yager, Jerome Y.

In: Pediatric Neurology, Vol. 32, No. 1, 01.01.2005, p. 18-24.

Research output: Contribution to journalArticle

Eicher, DJ, Wagner, CL, Katikaneni, LP, Hulsey, TC, Bass, WT, Kaufman, DA, Horgan, MJ, Languani, S, Bhatia, JJ, Givelichian, LM, Sankaran, K & Yager, JY 2005, 'Moderate hypothermia in neonatal encephalopathy: Safety outcomes', Pediatric Neurology, vol. 32, no. 1, pp. 18-24. https://doi.org/10.1016/j.pediatrneurol.2004.06.015
Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA et al. Moderate hypothermia in neonatal encephalopathy: Safety outcomes. Pediatric Neurology. 2005 Jan 1;32(1):18-24. https://doi.org/10.1016/j.pediatrneurol.2004.06.015
Eicher, Dorothea J. ; Wagner, Carol L. ; Katikaneni, Lakshmi P. ; Hulsey, Thomas C. ; Bass, W. Thomas ; Kaufman, David A. ; Horgan, Michael J. ; Languani, Sheila ; Bhatia, Jatinder J ; Givelichian, Lawrence M. ; Sankaran, Koravangatta ; Yager, Jerome Y. / Moderate hypothermia in neonatal encephalopathy : Safety outcomes. In: Pediatric Neurology. 2005 ; Vol. 32, No. 1. pp. 18-24.
@article{96a30ddc55804650902ac8e5687962f0,
title = "Moderate hypothermia in neonatal encephalopathy: Safety outcomes",
abstract = "Hypoxic-ischemic injury may cause multisystem organ damage with significant aberrations in clotting, renal, and cardiac functions. Systemic hypothermia may aggravate these medical conditions, such as bradycardia and increased clotting times, and very little safety data in neonatal hypoxic-ischemic injury is available. This study reports a multicenter, randomized, controlled pilot trial of moderate systemic hypothermia (33°C) vs normothermia (37°C) for 48 hours in infants with neonatal encephalopathy instituted within 6 hours of birth or hypoxic-ischemic event. The best outcome measures of safety were determined, comparing rates of adverse events between normothermia and hypothermia groups. A total of 32 hypothermia and 33 normothermia neonates were enrolled in seven centers. Adverse events and serious adverse effects were collected by the study team during the hospital admission, monitored by an independent study monitor, and reported to Institutional Review Boards and the Data and Safety Monitoring Committee. The following adverse events were observed significantly more commonly in the hypothermia group: more frequent bradycardia and lower heart rates during the period of hypothermia, longer dependence on pressors, higher prothrombin times, and lower platelet counts with more patients requiring plasma and platelet transfusions. Seizures as an adverse event were more common in the hypothermia group. These observed side effects of 48 hours of moderate systemic hypothermia were of mild to moderate severity and manageable with minor interventions.",
author = "Eicher, {Dorothea J.} and Wagner, {Carol L.} and Katikaneni, {Lakshmi P.} and Hulsey, {Thomas C.} and Bass, {W. Thomas} and Kaufman, {David A.} and Horgan, {Michael J.} and Sheila Languani and Bhatia, {Jatinder J} and Givelichian, {Lawrence M.} and Koravangatta Sankaran and Yager, {Jerome Y.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.pediatrneurol.2004.06.015",
language = "English (US)",
volume = "32",
pages = "18--24",
journal = "Pediatric Neurology",
issn = "0887-8994",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Moderate hypothermia in neonatal encephalopathy

T2 - Safety outcomes

AU - Eicher, Dorothea J.

AU - Wagner, Carol L.

AU - Katikaneni, Lakshmi P.

AU - Hulsey, Thomas C.

AU - Bass, W. Thomas

AU - Kaufman, David A.

AU - Horgan, Michael J.

AU - Languani, Sheila

AU - Bhatia, Jatinder J

AU - Givelichian, Lawrence M.

AU - Sankaran, Koravangatta

AU - Yager, Jerome Y.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Hypoxic-ischemic injury may cause multisystem organ damage with significant aberrations in clotting, renal, and cardiac functions. Systemic hypothermia may aggravate these medical conditions, such as bradycardia and increased clotting times, and very little safety data in neonatal hypoxic-ischemic injury is available. This study reports a multicenter, randomized, controlled pilot trial of moderate systemic hypothermia (33°C) vs normothermia (37°C) for 48 hours in infants with neonatal encephalopathy instituted within 6 hours of birth or hypoxic-ischemic event. The best outcome measures of safety were determined, comparing rates of adverse events between normothermia and hypothermia groups. A total of 32 hypothermia and 33 normothermia neonates were enrolled in seven centers. Adverse events and serious adverse effects were collected by the study team during the hospital admission, monitored by an independent study monitor, and reported to Institutional Review Boards and the Data and Safety Monitoring Committee. The following adverse events were observed significantly more commonly in the hypothermia group: more frequent bradycardia and lower heart rates during the period of hypothermia, longer dependence on pressors, higher prothrombin times, and lower platelet counts with more patients requiring plasma and platelet transfusions. Seizures as an adverse event were more common in the hypothermia group. These observed side effects of 48 hours of moderate systemic hypothermia were of mild to moderate severity and manageable with minor interventions.

AB - Hypoxic-ischemic injury may cause multisystem organ damage with significant aberrations in clotting, renal, and cardiac functions. Systemic hypothermia may aggravate these medical conditions, such as bradycardia and increased clotting times, and very little safety data in neonatal hypoxic-ischemic injury is available. This study reports a multicenter, randomized, controlled pilot trial of moderate systemic hypothermia (33°C) vs normothermia (37°C) for 48 hours in infants with neonatal encephalopathy instituted within 6 hours of birth or hypoxic-ischemic event. The best outcome measures of safety were determined, comparing rates of adverse events between normothermia and hypothermia groups. A total of 32 hypothermia and 33 normothermia neonates were enrolled in seven centers. Adverse events and serious adverse effects were collected by the study team during the hospital admission, monitored by an independent study monitor, and reported to Institutional Review Boards and the Data and Safety Monitoring Committee. The following adverse events were observed significantly more commonly in the hypothermia group: more frequent bradycardia and lower heart rates during the period of hypothermia, longer dependence on pressors, higher prothrombin times, and lower platelet counts with more patients requiring plasma and platelet transfusions. Seizures as an adverse event were more common in the hypothermia group. These observed side effects of 48 hours of moderate systemic hypothermia were of mild to moderate severity and manageable with minor interventions.

UR - http://www.scopus.com/inward/record.url?scp=19944380119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944380119&partnerID=8YFLogxK

U2 - 10.1016/j.pediatrneurol.2004.06.015

DO - 10.1016/j.pediatrneurol.2004.06.015

M3 - Article

C2 - 15607599

AN - SCOPUS:19944380119

VL - 32

SP - 18

EP - 24

JO - Pediatric Neurology

JF - Pediatric Neurology

SN - 0887-8994

IS - 1

ER -